| Pharmaceutical Information |
| Drug Name |
Sodium iodide i-123 |
| Drug ID |
BADD_D02042 |
| Description |
Sodium iodide is a water-soluble ionic compound with a crystal lattice. Sodium iodide is a source of iodine and can be administered as a supplement for total parenteral nutrition [L2065] but is more commonly used in veterinary medicine. Radiolabelled compound, [DB09293], is used as a diagnostic tool to evaluate thyroid function and morphology. |
| Indications and Usage |
Indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN) [L2065]. |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB11119
|
| KEGG ID |
D05863; D05328; D04874
|
| MeSH ID |
D012974
|
| PubChem ID |
11954386
|
| TTD Drug ID |
D07AAN
|
| NDC Product Code |
72536-0219; 17156-945; 72536-0218 |
| UNII |
29UKX3A616
|
| Synonyms |
Sodium Iodide |
|
| Chemical Information |
| Molecular Formula |
INa |
| CAS Registry Number |
41927-88-2 |
| SMILES |
[Na+].[I-] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Chest pain | 02.02.02.011; 08.01.08.002; 22.12.02.003 | - | - | - | | Nausea | 07.01.07.001 | - | - | | | Pruritus | 23.03.12.001 | - | - | | | Rash | 23.03.13.001 | - | - | - | | Tachycardia | 02.03.02.007 | - | - | - | | Urticaria | 10.01.06.001; 23.04.02.001 | - | - | | | Vomiting | 07.01.07.003 | - | - | |
|
The 1th Page
1
Total 1 Pages
|
|
